Madison Dearborn Partners agrees to buy majority stake in Ikaria

Madison Dearborn Partners said Tuesday that it has agreed to acquire a majority stake in Ikaria in a transaction valued at approximately $1.6 billion. Existing Ikaria shareholders, which include New Mountain Capital and members of the company’s management team, will receive a minority stake. Credit Suisse is advising Ikaria on the deal while Madison Dearborn is being advised by Barclays and Goldman Sachs. Headquartered in Hampton, NJ, Ikaria is a provider of proprietary and innovative therapies for the critical care units in hospitals.

24 December 2013•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles